{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Blood Podcast","title":"Trials without as Many Tribulations: Aplastic Anemia and Large B-cell lymphoma","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/0038f0cc\"></iframe>","width":"100%","height":180,"duration":1841,"description":"In this week's episode, Blood editor Dr. Laurie Sehn interviews Dr. Britta Höchsmann of the University of Ulm, Germany, and Dr. Lorenzo Falchi of the Memorial Sloan Kettering Cancer Center, NY, on their latest articles published in Blood discussing two important advances in hematologic treatment. Dr. Hochsmann reviews a phase III, placebo-controlled trial evaluating eltrombopag plus cyclosporine A for moderate aplastic anemia, demonstrating a significantly higher overall response rate with combination therapy (71.4%) compared with cyclosporine alone (42.5%), without new major safety concerns. Dr. Falchi discusses a phase I/II trial combining the bispecific antibody epcoritamab with R-CHOP in patients with newly diagnosed high-risk large B-cell lymphoma, reporting an overall response rate of 98% and a complete response rate of 85%, with encouraging progression-free survival and minimal residual disease clearance. Both discussions highlight the potential for these combination approaches to improve frontline treatment outcomes while emphasizing the importance of long-term follow-up, patient-centered outcomes, and further research to optimize treatment selection and duration.\nFeatured Articles\nEltrombopag plus cyclosporine for moderate aplastic anemia: a placebo-controlled, double-blind phase 3 trial\nFixed-duration epcoritamab plus R-CHOP for newly diagnosed LBCL with an IPI score of 3 to 5: results from the EPCORE NHL-2 trial","thumbnail_url":"https://img.transistorcdn.com/v7MGyoJEM-ebFBYi5VpSwDRF3QY3zbinfCyyOAH1TGk/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kY2Q4/YzJhZmMwODBjOWRi/YTNhN2Y1NWJkMzMw/NTBjZi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}